Predictive value of common genetic variants in idiopathic pulmonary fibrosis survival
Autores da FMUP
Participantes de fora da FMUP
- Mota, PC
- Vasconcelos, CD
- Ferreira, AC
- Lima, BA
- Manduchi, E
- Moore, JH
- Melo, N
- Pereira, JM
- Guimaraes, S
- Moura, CS
- Marques, JA
Unidades de investigação
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial pneumonia of unknown etiology. The role of genetic risk factors has been the focus of numerous studies probing for associations of genetic variants with IPF. We aimed to determine whether single-nucleotide polymorphisms (SNPs) of four candidate genes are associated with IPF susceptibility and survival in a Portuguese population. A retrospective case-control study was performed with 64 IPF patients and 74 healthy controls. Ten single-nucleotide variants residing in the MUC5B, TOLLIP, SERPINB1, and PLAU genes were analyzed. Single- and multi-locus analyses were performed to investigate the predictive potential of specific variants in IPF susceptibility and survival. Multifactor dimensionality reduction (MDR) was employed to uncover predictive multi-locus interactions underlying IPF susceptibility. The MUC5B rs35705950 SNP was significantly associated with IPF: T allele carriers were significantly more frequent among IPF patients (75.0% vs 20.3%, P < 1.0 x 10(-6)). Genotypic and allelic distributions of TOLLIP, PLAU, and SERPINB1 SNPs did not differ significantly between groups. However, the MUC5B-TOLLIP T-C-T-C haplotype, defined by the rs35705950-rs111521887-rs5743894-rs5743854 block, emerged as an independent protective factor in IPF survival (HR = 0.37, 95% CI 0.17-0.78, P = 0.009, after adjustment for FVC). No significant multi-locus interactions correlating with disease susceptibility were detected. MUC5B rs35705950 was linked to an increased risk for IPF, as reported for other populations, but not to disease survival. A haplotype incorporating SNPs of the MUC5B-TOLLIP locus at 11p15.5 seems to predict better survival and could prove useful for prognostic purposes and IPF patient stratification. Key messages The MUC5B rs35705950 minor allele is associated with IPF risk in the Portuguese. No predictive multi-locus interactions of IPF susceptibility were identified by MDR. A haplotype defined by MUC5B and TOLLIP SNPs is a protective factor in IPF survival. The haplotype may be used as a prognostic tool for IPF patient stratification.
Dados da publicação
- ISSN/ISSNe:
- 0946-2716, 1432-1440
- Tipo:
- Article
- Páginas:
- 1341-1353
- Link para outro recurso:
- www.scopus.com
JOURNAL OF MOLECULAR MEDICINE-JMM Springer Verlag
Citações Recebidas na Web of Science: 3
Citações Recebidas na Scopus: 7
Documentos
- Não há documentos
Filiações
Keywords
- Idiopathic pulmonary fibrosis; TOLLIP; MUC5B promoter; Haplotypes; IPF survival; Common genetic variants
Campos de estudo
Proyectos asociados
Fibrosing ILD Biomarkers That Rule Acceleration (FIBRALUNG) -NCT05635032
Investigador Principal: Hélder Novais e Bastos
Estudo Observacional Académico (FIBRALUNG) . FCT . 2021
Chronic Bronchopulmonary aspergillosis patients with underlying chronic obstructive pulmonary disease: providing grounds for biomarkers search through clinical phenotyping
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2020
Impact of Chronic Obstructive Pulmonary Disease in surgical outcomes of lung cancer patients undergoing curative intent surgery
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2021
Pulmonary Emphysema Regional Distribution and Extent from Chest Computed Tomography is Associated with Pulmonary Function Impairment in COPD Patients.
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2021
Non-invasive assessment of Benign Tracheal Stenosis.
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2020
Citar a publicação
Mota PC,Soares ML,Vasconcelos CD,Ferreira AC,Lima BA,Manduchi E,Moore JH,Melo N,Novais H,Pereira JM,Guimaraes S,Moura CS,Marques JA,Morais A. Predictive value of common genetic variants in idiopathic pulmonary fibrosis survival. J. Mol. Med. 2022. 100. (9):p. 1341-1353. IF:4,700. (1).